Identification of the metabolites of nimbolide in rat by liquid chromatography combined with quadrupole/orbitrap mass spectrometry

Kun Li,Lingling Jiang,Yubao Wei,Zeyun Li
DOI: https://doi.org/10.1002/bmc.6012
2024-10-04
Biomedical Chromatography
Abstract:Nimbolide is a major furanoid compound isolated from Azadirachta indica. The aim of this study was to characterize the metabolites of nimbolide in rats and to propose the metabolic pathways. The metabolites were generated by incubating nimbolide (10 μM) with rat liver microsomes, nicotinamide adenine dinucleotide phosphate (NADPH), and nucleophiles (glutathione [GSH] or N‐acetyl‐lysine [NAL]) at 37°C for 60 min. For the in vivo study, nimbolide was intravenously administered to rats at a single dose of 10 mg/kg, and the bile and urine were collected. The metabolites were identified by ultra‐high‐performance liquid chromatography‐quadrupole/orbitrap mass spectrometry (UPLC‐Q/Orbitrap‐MS) using electrospray ionization in positive ion mode. Totally, nine metabolites were detected, and their identities were characterized by accurate MS and MS/MS data. In GSH‐supplemented liver microsomes, GSH conjugation was the primary elimination pathway. The furan ring was bioactivated into cis‐butene‐1,4‐dial that can be trapped by GSH. In NAL‐supplemented liver microsomes, two NAL conjugates (M4 and M5) derived from cis‐butene‐1,4‐dial were observed. In rat bile and urine, N‐acetyl‐cysteine, cysteine‐glycine, and GSH conjugate were also found. The current study provides an overview of the metabolism and the bioactivation profiles of nimbolide in rats, which aids in understanding its safety and activity.
pharmacology & pharmacy,biochemistry & molecular biology,biochemical research methods,chemistry, analytical
What problem does this paper attempt to address?